Table 5 Cox regression to evaluate prognostication of tumor sizing parameters
From: A new relative tumor sizing method in epi-metaphyseal osteosarcoma
5-year survival | Metastasis | ||||
|---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | ||
At diagnosis (n = 41) | ATL | 1.005 (0.995 to 1.015) | 0.324 | 1.005 (0.996 to 1.014) | 0.291 |
ATV | 1.000 (0.997 to 1.003) | 0.918 | 1.000 (0.997 to 1.003) | 0.955 | |
RTV | 0.999 (0.994 to 1.005) | 0.839 | 1.000 (0.994 to 1.005) | 0.871 | |
ATA | 1.019 (0.988 to 1.050) | 0.232 | 1.024 (0.996 to 1.054) | 0.099 | |
TAR | 1.031 (0.153 to 6.950) | 0.975 | 4.748 (0.689 to 32.730) | 0.114 | |
After Neoadjuvant Chemotherapy (n = 57) | ATL | 1.003 (0.994 to 1.012) | 0.560 | 1.004 (0.996 to 1.012) | 0.281 |
ATV | 1.003 (0.997 to 1.009) | 0.338 | 1.004 (0.998 to 1.009) | 0.155 | |
RTV | 1.002 (0.992 to 1.012) | 0.651 | 1.005 (0.997 to 1.014) | 0.218 | |
ATA | 1.070 (1.030 to 1.112) | <0.001 | 1.073 (1.035 to 1.112) | <0.001 | |
TAR | 5.931 (1.153 to 30.513) | 0.033 | 14.144 (2.826 to 70.784) | 0.001 | |